Aptar Pharma at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

Aptar Pharma takes part in 1 session at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits. Its program centres on vaccines given through the nose. It covers the key choices in developing a nasal vaccine, including targeting where the dose lands and keeping the biological ingredient compatible with the delivery device, the area of its nasal delivery work.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
aptar.com/pharma
Bioprocess & manufacturingAssociate sponsor
Drug delivery partner supplying delivery devices, formulation and development services, including nasal delivery, to pharmaceutical companies worldwide.
Booth
Exhibiting (no floor booth listed)
Talk
Wed Oct 21
11:15
Critical Considerations in Nasal Vaccine Development: Targeted Delivery, and Biologic Compatibility
AMR & Bacterial Vaccines

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Aptar Pharma

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction